Dr. Steven Sparagana’s dedication and pioneering work have been instrumental in advancing tuberous sclerosis complex (TSC)
research and improving the lives of countless individuals and families affected by this disease. He has served proudly as the TSC Clinic Director at Scottish Rite for Children in Dallas, Texas for the past 24 years and helped generations of families. Dr. Sparagana and his team have participated in pivotal clinical trials leading to FDA-approved drugs for TSC. He has also served for more than two decades on the TSC Alliance Professional Advisory Board
In recognition of Dr. Sparagana’s extraordinary contributions and his upcoming retirement, we are proud to announce the creation of the Steven Sparagana Legacy Fund. This fund is dedicated to ensuring that Dr. Sparagana’s groundbreaking work and visionary leadership will continue to drive progress in TSC research and patient care for many years to come.
Learn more about the Steven Sparagana Legacy Fund here.